Ticker	Volume	Price	Price Delta
DJIA	12,454.80	-74.92	-0.60%
S&P 500	1,317.82	-2.86	-0.22%
Nasdaq	2,837.53	-1.85	-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,161.87	+5.35	0.25%
FTSE 100	5,351.53	+1.48	0.03%
DAX	6,339.94	+24.05	0.38%

Ticker	Volume	Price	Price Delta
Nikkei	8,580.39	+17.01	0.20%
TOPIX	722.11	-0.14	-0.02%
Hang Seng	18,713.40	+47.01	0.25%

Gold

1,571.20

+0.73%

EUR-USD

1.2578

0.4905%

Nasdaq

2,837.53

-0.07%

DJIA

12,454.80

-0.60%

S&P 500

1,317.82

-0.22%

FTSE 100

5,351.53

+0.03%

STOXX 50

2,161.87

+0.25%

DAX

6,339.94

+0.38%

Oil (WTI)

90.86

+0.22%

U.S. 10-year

1.738%

-0.039

BAC:US

7.15

+0.14%

FB:US

31.91

-3.39%

Bloomberg

Exchange: -
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Drugs

Axcan Pharma Inc

AXCA:US

Acquired

Axcan Pharma Inc (AXCA:US) was acquired by 8818Z:US

Company Profile

Axcan Pharma Inc. operates as a pharmaceutical company. The Company researches, develops, and distributes pharmaceutical products for the treatment of symptons of gastrointestinal diseases and disorders including inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases, and complications related to cystic fibrosis.